.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Predict branded drug patent expiration

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Baxter
Express Scripts
AstraZeneca
Covington
Cantor Fitzgerald
Accenture
Fuji
Teva
QuintilesIMS

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078008

« Back to Dashboard
NDA 078008 describes MELOXICAM, which is a drug marketed by Taro, Aurobindo Pharma, Yung Shin Pharm, Breckenridge Pharm, Zydus Pharms Usa, Mylan, Roxane, Unichem, Strides Pharma, Cipla Ltd, Corepharma, Dr Reddys Labs Inc, Glenmark Generics, Yabao Pharm, Frontida Biopharm, Teva Pharms, Sun Pharm Inds Inc, Puracap Pharm, Cr Double Crane, Lupin Pharms, and Apotex Inc, and is included in twenty-two NDAs. It is available from fifty-one suppliers. Additional details are available on the MELOXICAM profile page.

The generic ingredient in MELOXICAM is meloxicam. There are twenty-two drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the meloxicam profile page.

Summary for NDA: 078008

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 078008

Suppliers and Packaging for NDA: 078008

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MELOXICAM
meloxicam
TABLET;ORAL 078008 ANDA Aurobindo Pharma Limited 65862-097 65862-097-01 100 TABLET in 1 BOTTLE (65862-097-01)
MELOXICAM
meloxicam
TABLET;ORAL 078008 ANDA Aurobindo Pharma Limited 65862-097 65862-097-05 500 TABLET in 1 BOTTLE (65862-097-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength7.5MG
Approval Date:Oct 2, 2006TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength15MG
Approval Date:Oct 2, 2006TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
UBS
Queensland Health
Accenture
Novartis
McKesson
Daiichi Sankyo
Mallinckrodt
Healthtrust
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot